SCHEMBL1348145

SCHEMBL1348145

NC(=O)c1cccc(-c2ccc(CNCCc3cccc(F)c3)cc2)c1

nearest known ligand 0.57

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
OPRM1 P35372 3/20 0.57
OPRD1 P41143 3/20 0.57
OPRK1 P41145 3/20 0.57
MEN1 O00255 1/20 0.49
KMT2A Q03164 1/20 0.49
NOS1 P29475 2/20 0.48
KDM4E B2RXH2 2/20 0.48
ALDH1A1 P00352 1/20 0.48
PARP1 P09874 1/20 0.48
HDAC1 Q13547 2/20 0.47
SRC P12931 1/20 0.46
CDC7 O00311 1/20 0.46
ROCK2 O75116 1/20 0.46
MAP4K4 O95819 1/20 0.46
PIM1 P11309 1/20 0.46
CDK2 P24941 1/20 0.46
GSK3B P49841 1/20 0.46
CLK4 Q9HAZ1 1/20 0.46
DPP4 P27487 1/20 0.46
MPO P05164 1/20 0.45

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL12607844 0.95 OPRM1 (0.52) OPRM1OPRD1OPRK1MEN1KMT2A
Hydrochloric Acid SCHEMBL3339542 0.94 OPRM1 (0.52) OPRM1OPRD1OPRK1MEN1KMT2A
SCHEMBL1786063 0.91 KDM4E (0.56) OPRM1OPRD1OPRK1KDM4EALDH1A1
SCHEMBL1347601 0.91 KDM4E (0.56) OPRM1OPRD1OPRK1KDM4EALDH1A1
SCHEMBL1788221 0.90 OPRM1 (0.54) OPRM1OPRD1OPRK1PARP1SRC
Hydrochloric Acid SCHEMBL3345306 0.89 KDM4E (0.55) OPRM1OPRD1OPRK1KDM4EALDH1A1
SCHEMBL1347867 0.88 OPRM1 (0.62) OPRM1OPRD1OPRK1MEN1KMT2A
SCHEMBL3341545 0.88 OPRM1 (0.62) OPRM1OPRD1OPRK1MEN1KMT2A
SCHEMBL15434277 0.86 OPRM1 (0.50) OPRM1OPRD1OPRK1KDM4EALDH1A1
SCHEMBL1348560 0.85 KDM4E (0.56) OPRM1OPRD1OPRK1MEN1KMT2A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 8 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-8063247-B2 Bicyclic aryl and heteroaryl receptor modulators PROSIDION LIMITED (GB) 2011-11-22 US claimed
US-8063247-B2 Bicyclic aryl and heteroaryl receptor modulators PROSIDION LIMITED (GB) 2011-11-22 US disclosed
US-8063247-B2 Bicyclic aryl and heteroaryl receptor modulators PROSIDION LIMITED (GB) 2011-11-22 US disclosed
US-8063247-B2 Bicyclic aryl and heteroaryl receptor modulators PROSIDION LIMITED (GB) 2011-11-22 US disclosed
US-20100267780-A1 BICYCLIC ARYL AND HETEROARYL RECEPTOR MODULATORS PROSIDION LIMITED (GB) 2010-10-21 US disclosed
US-20100267780-A1 BICYCLIC ARYL AND HETEROARYL RECEPTOR MODULATORS PROSIDION LIMITED (GB) 2010-10-21 US disclosed
US-20100267780-A1 BICYCLIC ARYL AND HETEROARYL RECEPTOR MODULATORS PROSIDION LIMITED (GB) 2010-10-21 US disclosed
WO-2009030962-A1 BICYCLIC ARYL AND HETEROARYL RECEPTOR MODULATORS PROSIDION LIMITED (GB) 2009-03-12 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20100267780-A1 BICYCLIC ARYL AND HETEROARYL RECEPTOR MODULATORS OPRM1, OPRL1, OPRD1 OPRM1 1/4885OPRD1 3/4885OPRK1 4/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.